Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Fortum and associated names

Product name: Fortum and associated names
Also marketed in the EU under the name(s): Cefortam , Fortam, Fortum , Fortum enfants et nourrisons , Fortum Monovial , Fortumset , Glazidim , Solvetan
Active substance: Ceftazidime
Indication: Fortum is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).
- Nosocomial pneumonia
- Broncho-pulmonary infections in cystic fibrosis>
- Bacterial meningitis
- Chronic suppurative otitis media
- Malignant otitis externa
- Complicated urinary tract infections
- Complicated skin and soft tissue infections
- Complicated intra-abdominal infections
- Bone and joint infections
- Peritonitis associated with dialysis in patients on CAPD.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/01/2011 Referral EMEA/H/A-30/1006 (2011)193 of 13/01/2011